 
 PURE Bioscience, Inc.
OTC:PURE
0.11 (USD) • At close November 27, 2023
 Overzicht | Financiële gegevens
 | Bedrijfsnaam | PURE Bioscience, Inc. | 
| Symbool | PURE | 
| Munteenheid | USD | 
| Prijs | 0.107 | 
| Beurswaarde | 11,968,592 | 
| Dividendpercentage | 0% | 
| 52-weken bereik | 0.07 - 0.2 | 
| Industrie | Household & Personal Products | 
| Sector | Consumer Defensive | 
| CEO | Mr. Robert F. Bartlett | 
| Website | https://www.purebio.com | 
An error occurred while fetching data.
Over PURE Bioscience, Inc.
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with 
 Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)





